CSF2 and breast carcinoma: In addition, Stattic treatment abolished rhG-CSF-mediated upregulation of mesenchymal markers at both protein and mRNA levels (Figure 6D and E), indicating that G-CSF/Stat3 signaling is able to promote EMT of breast cancer cells.